Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Unquoted Biotechs -- Ignore unavailable to you. Want to Upgrade?

To: bob zagorin who wrote (197)	10/14/2007 2:10:29 PM
From: DewDiligence_on_SI	Respond to of 253

5) GTC Biotherapeutics (GTCB): Recently received good news of fast-track FDA designation & permission for rolling BLA app for Atryn, which is already approved in Europe & is produced by GTC's novel transgenic protein technology, which allows complex human proteins to be produced & purified in goats by inserting human DNA into the animals. GTC anticipates filing the initial sections with the FDA in 4Q07 and completing the rolling submission after all clinical data is gathered, analyzed, and available for the BLA, which is planned by end 1Q08. This is slightly out of date: the BLA submission has been pushed back to mid 2008: siliconinvestor.com Regards, Dew

To: bob zagorin who wrote (197)	10/15/2007 1:40:04 AM
From: tuck	Respond to of 253

Why is this post even here? All of these biotechs are quoted, publicly traded in this country. I say throw it on the valuation thread. I know the thread header doesn't explicitly say this, but really, it's for tracking certain interesting private companies. Have you read through a bit of it? FWIW, since the post is in play . . . I own GTCB now, and a smidge of ZGEN (used to own more, & would buy more on even marginal weakness (i.e. if it drops a buck or so)), tempted by JAV (which is well followed on IHub}. NTEC . . . can they really get around Amgen's IP with their formulation? I have no clue, just asking . . . though I'd guess that if Roche loses in court with Cera (which is PEGged with NKTR technology), NTEC also has little chance. Cheers, Tuck